Gankyrin gene deletion followed by proteomic analysis: Insight into the roles of Gankyrin in Tumorigenesis and Metastasis

BMC Medical Genomics

Volumn 5, Issue , 2012, Pages

  Luo, Xue ^a,b   Chen, Liang ^a   Dai, Jiang ^a   Gao, Yanfei ^a   Wang, Hongli ^a   Wang, Na ^a   Zhao, Yongqiang ^a   Liu, Feng ^a   Sang, Zhihong ^a   Wang, Jie ^a   Li, Weihua ^a   He, Kun ^a   Jin, Baofeng ^a   Man, Jianghong ^a   Zhang, Wei ^c   Xia, Qing ^a  

^a NATIONAL CENTER OF BIOMEDICAL ANALYSIS   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

^c Beijing 307 Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; ONCOPROTEIN; PROTEIN GANKYRIN; PROTEOME; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANCHORAGE INDEPENDENT GROWTH; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CARCINOGENESIS; CELL MIGRATION; CELL PROLIFERATION; COLON CANCER; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE INACTIVATION; GENE TARGETING; GENETIC RECOMBINATION; HUMAN; HUMAN CELL; METASTASIS; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEOMICS;

CELL MOVEMENT; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; COLONIC NEOPLASMS; GENE DELETION; GENE KNOCKOUT TECHNIQUES; HCT116 CELLS; HUMANS; NEOPLASM METASTASIS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEOMICS; PROTO-ONCOGENE PROTEINS;

EID: 84865172216     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-5-36     Document Type: Article

References (26)

1. Gankyrin: an intriguing name for a novel regulator of p53 and RB. Lozano G, Zambetti GP, Cancer Cell 2005 8 1 3 4 10.1016/j.ccr.2005.06.014 16023592
2. Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomas. Higashitsuji H, Itoh K, Nagao T, Dawson S, Nonoguchi K, Kido T, Mayer RJ, Arii S, Fujita J, Nat Med 2000 6 1 96 99 10.1038/71600 10613832
3. The oncoprotein p28GANK establishes a positive feedback loop in beta-catenin signaling. Dong LW, Yang GZ, Pan YF, Chen Y, Tan YX, Dai RY, Ren YB, Fu J, Wang HY, Cell Res 2011 21 8 1248 1261 10.1038/cr.2011.103 21691299
4. The oncoprotein gankyrin binds to MDM2/HDM2, enhancing ubiquitylation and degradation of p53. Higashitsuji H, Higashitsuji H, Itoh K, Sakurai T, Nagao T, Sumitomo H, Masuda T, Dawson S, Shimada Y, Mayer RJ, Fujita J, Cancer Cell 2005 8 1 75 87 10.1016/j.ccr.2005.06.006 16023600
5. Gankyrin plays an essential role in Ras-induced tumorigenesis through regulation of the RhoA/ROCK pathway in mammalian cells. Man JH, Liang B, Gu YX, Zhou T, Li AL, Li T, Jin BF, Bai B, Zhang HY, Zhang WN, et al. J Clin Invest 2010 120 8 2829 2841 10.1172/JCI42542 20628200
6. Gankyrin promotes the proliferation of human pancreatic cancer. Meng Y, He L, Guo X, Tang S, Zhao X, Du R, Jin J, Bi Q, Li H, Nie Y, et al. Cancer Lett 2010 297 1 9 17 10.1016/j.canlet.2010.04.019 20483533
7. Overexpression of a novel gene gankyrin correlates with the malignant phenotype of colorectal cancer. Tang S, Yang G, Meng Y, Du R, Li X, Fan R, Zhao L, Bi Q, Jin J, Gao L, et al. Cancer Biol Ther 2010 9 2 88 95 10.4161/cbt.9.2.10283 19901563
8. Proteomics analysis reveals insight into the mechanism of H-Ras-mediated transformation. Jin BF, He K, Wang HX, Bai B, Zhou T, Li HY, Man JH, Liu BY, Gong WL, Wang J, et al. J Proteome Res 2006 5 10 2815 2823 10.1021/pr060283f 17022653
9. Genetic knockouts and knockins in human somatic cells. Rago C, Vogelstein B, Bunz F, Nat Protoc 2007 2 11 2734 2746 10.1038/nprot.2007.408 18007609
10. Expression profiling reveals off-target gene regulation by RNAi. Jackson AL, Bartz SR, Schelter J, Kobayashi SV, Burchard J, Mao M, Li B, Cavet G, Linsley PS, Nat Biotechnol 2003 21 6 635 637 10.1038/nbt831 12754523
11. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP, Sedivy JM, Kinzler KW, Vogelstein B, Science 1998 282 5393 1497 1501 9822382
12. Induction of SOX4 by DNA damage is critical for p53 stabilization and function. Pan X, Zhao J, Zhang WN, Li HY, Mu R, Zhou T, Zhang HY, Gong WL, Yu M, Man JH, et al. Proc Natl Acad Sci USA 2009 106 10 3788 3793 10.1073/pnas.0810147106 19234109
13. p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase. Jiang P, Du W, Wang X, Mancuso A, Gao X, Wu M, Yang X, Nat Cell Biol 2011 13 3 310 316 10.1038/ncb2172 21336310
14. Genetic disruption of PPARdelta decreases the tumorigenicity of human colon cancer cells. Park BH, Vogelstein B, Kinzler KW, Proc Natl Acad Sci USA 2001 98 5 2598 2603 10.1073/pnas.051630998 11226285
15. Inactivation of hCDC4 can cause chromosomal instability. Rajagopalan H, Jallepalli PV, Rago C, Velculescu VE, Kinzler KW, Vogelstein B, Lengauer C, Nature 2004 428 6978 77 81 10.1038/nature02313 14999283
16. Autoantibody profiling of Chinese patients with autoimmune hepatitis using immunoproteomic analysis. Xia Q, Lu F, Yan HP, Wang HX, Feng X, Zhao Y, Liu BY, Wang J, Li P, Xue Y, et al. J Proteome Res 2008 7 5 1963 1970 10.1021/pr700861s 18355017
17. Mass spectrometric characterization of the affinity-purified human 26S proteasome complex. Wang X, Chen CF, Baker PR, Chen PL, Kaiser P, Huang L, Biochemistry 2007 46 11 3553 3565 10.1021/bi061994u 17323924
18. The oncoprotein gankyrin binds to MDM2/HDM2, enhancing ubiquitylation and degradation of p53. Higashitsuji H, Itoh K, Sakurai T, Nagao T, Sumitomo Y, Masuda T, Dawson S, Shimada Y, Mayer RJ, Fujita J, Cancer Cell 2005 8 1 75 87 10.1016/j.ccr.2005.06.006 16023600
19. Cofilin determines the migration behavior and turning frequency of metastatic cancer cells. Sidani M, Wessels D, Mouneimne G, Ghosh M, Goswami S, Sarmiento C, Wang W, Kuhl S, El-Sibai M, Backer JM, et al. J Cell Biol 2007 179 4 777 791 10.1083/jcb.200707009 18025308
20. The mitotic kinase Aurora-A induces mammary cell migration and breast cancer metastasis by activating the Cofilin-F-actin pathway. Wang LH, Xiang J, Yan M, Zhang Y, Zhao Y, Yue CF, Xu J, Zheng FM, Chen JN, Kang Z, et al. Cancer Res 2010 70 22 9118 9128 10.1158/0008-5472.CAN-10-1246 21045147
21. Cytoplasmic p21Cip1 is involved in Ras-induced inhibition of the ROCK/LIMK/cofilin pathway. Lee S, Helfman DM, J Biol Chem 2004 279 3 1885 1891 10.1074/jbc.M306968200 14559914
22. The cofilin pathway in breast cancer invasion and metastasis. Wang W, Eddy R, Condeelis J, Nat Rev Cancer 2007 7 6 429 440 10.1038/nrc2148 17522712
23. The role of annexin A2 in tumorigenesis and cancer progression. Lokman NA, Ween MP, Oehler MK, Ricciardelli C, Cancer Microenviron 2011 4 2 199 208 10.1007/s12307-011-0064-9 21909879
24. The role of annexin II in angiogenesis and tumor progression: a potential therapeutic target. Sharma MC, Sharma M, Curr Pharm Des 2007 13 35 3568 3575 10.2174/138161207782794167 18220793
25. Targeting 14-3-3zeta in cancer therapy. Yang X, Cao W, Zhang L, et al. Cancer Gene Ther 2012 19 153 159 10.1038/cgt.2011.85 22193627
26. 14-3-3 regulates actin dynamics by stabilizing phosphorylated cofilin. Gohla A, Bokoch GM, Curr Biol 2002 12 1704 1710 10.1016/S0960-9822(02)01184-3 12361576